ARCHIVES

Study Finds Short Term Tests Predict Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 06 No. 17 | April 25, 1980

Download PDF Visit The Full Archive

Related Articles

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award

April 2, 1993